Microtest Diagnostics

About:

Microtest Diagnostics provides automated multiplex in vitro diagnostic tests for allergies, influenza, autoimmune, and infectious Disease.

Website: http://www.microtestdx.com

Twitter/X: allergydx

Top Investors: SyndicateRoom

Description:

Microtest Diagnostics was spun out of London’s Imperial College in 2002 with a mission to provide automated multiplex in-vitro diagnostic tests in the areas of Allergy, Autoimmune, Influenza and Infectious Disease. Following more than 10 years of development and over USD $10 million in R&D investment, Microtest Diagnostics recently CE-marked the ADAM™ instrument. The company operates with a highly skilled team of trained professionals with expertise across numerous fields including product, software and hardware design, instrument and assay development, regulatory approvals and quality control. Our facilities are certified ISO13485:2003 Medical devices and ISO 9001:2008 for the design and development of microarray test devices.

Total Funding Amount:

12.2M GBP

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

London, England, United Kingdom

Founded Date:

2001-01-01

Contact Email:

info(AT)microtestdx.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2016-01-27

IPO Status:

Private

Industries:

© 2025 bioDAO.ai